Myasthenia Gravis

Introduction

Myasthenia gravis, often shortened to MG, is a long-term condition in which certain muscles become weak and tire easily. The weakness comes and goes. It is often worse later in the day, after activity, or during illness, and it improves with rest. For many people, the first signs are drooping eyelids, double vision, a change in voice, difficulty chewing, or a sense that the arms and legs “run out of strength” quickly.

If you or a family member has been diagnosed with myasthenia gravis — or is being evaluated for it — this guide is written for you. It describes what MG is, how doctors diagnose and classify it, the treatments that are used today, what to expect during a flare or a crisis, and how the condition is managed over the long term. MG is a chronic condition, but it is also a very treatable one. Most people, with the right combination of medication and monitoring, are able to lead full and active lives.

What Is Myasthenia Gravis?

Myasthenia gravis is an autoimmune neuromuscular disorder. To understand what that means, it helps to picture how muscles normally work.

When your brain tells a muscle to move, a nerve carries that signal down to the muscle. Where the nerve meets the muscle, there is a tiny gap called the neuromuscular junction. The nerve releases a chemical messenger called acetylcholine into this gap. Acetylcholine then attaches to special docking points on the muscle, called acetylcholine receptors, and tells the muscle to contract.

In myasthenia gravis, the immune system — which normally protects you from infection — mistakenly makes antibodies that attack these receptors or the proteins that hold them in place. Fewer working receptors mean the muscle does not contract as strongly as it should, especially with repeated use. The muscle gets weaker the more it is used and recovers with rest. This is why the hallmark of MG is fluctuating, fatigable weakness.

MG affects voluntary muscles — the muscles you control on purpose — not the heart or the smooth muscle of the gut. It is not contagious. It is not inherited in most cases, although a small number of families have a higher tendency to develop autoimmune conditions in general.

Types of Myasthenia Gravis

Doctors usually group myasthenia gravis in two ways: by which muscles are affected, and by which antibody (if any) is found in the blood.

By the muscles involved

Ocular myasthenia gravis affects only the muscles around the eyes. The main symptoms are drooping of one or both eyelids (called ptosis) and double vision (diplopia). About half of people who start with ocular symptoms go on to develop weakness in other muscles within two years; the rest remain ocular only.

Generalised myasthenia gravis affects muscles beyond the eyes — the face, jaw, throat, neck, arms, legs, or the muscles used for breathing. Generalised MG can range from mild to severe.

By the antibody involved

AChR-antibody positive MG is the most common form. Antibodies are directed against the acetylcholine receptor itself. About 80 to 85 percent of people with generalised MG have these antibodies; the proportion is lower in ocular-only MG.

MuSK-antibody positive MG involves antibodies against a protein called muscle-specific kinase, which helps anchor acetylcholine receptors in place. MuSK-MG tends to affect bulbar muscles (face, jaw, throat, tongue) more prominently and may respond differently to standard treatments.

LRP4-antibody positive MG is a less common form involving antibodies against another junction protein.

Seronegative MG is the term used when none of these antibodies are found on standard tests, even though the clinical picture and other tests support MG. This does not mean the condition is less real; it usually means the antibodies are present at levels too low to detect, or are directed against targets not covered by routine blood tests.

Other forms

Transient neonatal myasthenia can occur in newborn babies of mothers with MG, when the mother’s antibodies cross the placenta. It is temporary and resolves within weeks as the antibodies clear from the baby’s system.

Congenital myasthenic syndromes are rare genetic conditions that look like MG but are not autoimmune. They are caused by inherited problems with the neuromuscular junction itself and need different treatment. These are covered briefly in the children’s section below.

Causes and Risk Factors

Myasthenia gravis is an autoimmune condition, which means it begins when the body’s immune system attacks part of its own tissue — in this case, the neuromuscular junction. Why this happens is not fully understood. There is no single cause, but several factors are known to be involved.

The thymus gland. The thymus is a small gland in the upper chest that helps train the immune system in childhood and shrinks during adulthood. In a large share of people with AChR-antibody positive MG, the thymus is abnormal — either enlarged with extra immune tissue (thymic hyperplasia) or, less commonly, containing a tumour called a thymoma. The thymus is thought to play a role in producing the abnormal antibodies, which is why removing it (thymectomy) is part of treatment for some patients.

Genetic background. MG is not directly inherited, but having other autoimmune conditions in the family — such as thyroid disease, rheumatoid arthritis, or type 1 diabetes — slightly raises the chance of developing MG. People with MG themselves are more likely to develop another autoimmune condition, particularly autoimmune thyroid disease.

Age and sex patterns. MG can begin at any age. It commonly appears in two patterns: women in their 20s and 30s, and men over 50. The condition is more common in women under 40 and more common in men over 60, although these patterns are not strict.

Triggers of flares. While these do not cause MG, they can worsen symptoms in someone who already has it. Common triggers include infections (especially chest and urinary infections), surgery and anaesthesia, certain medications, physical or emotional stress, pregnancy, hot weather, and missed doses of MG medication.

Several medications can worsen myasthenia gravis and need to be avoided or used with caution. These include some antibiotics (notably aminoglycosides and fluoroquinolones), certain heart medications (such as beta-blockers and some antiarrhythmics), magnesium-containing products given intravenously, and some muscle relaxants used during anaesthesia. Your treating neurologist can give you a list to share with any other doctor or dentist who treats you.

Signs and Symptoms

If you have been diagnosed with MG, you are likely already familiar with your own pattern of symptoms. This section describes the range, both to help recognise changes that may signal a flare and to give context to family members who want to understand what you experience.

The classic feature of MG is weakness that gets worse with use and better with rest. This is different from feeling tired in general — it is the muscle itself running out of strength after repeated activity.

Eye symptoms

• Drooping of one or both eyelids (ptosis), often worse at the end of the day
• Double vision (diplopia), which usually improves when one eye is covered
• Blurred vision that comes and goes

Bulbar symptoms (face, jaw, throat)

• Slurred or nasal-sounding speech, especially after long conversations
• Difficulty chewing, particularly with tough foods, with the jaw tiring partway through a meal
• Difficulty swallowing, sometimes with coughing or choking on food or liquids
• Change in facial expression, including a flat smile or trouble closing the eyelids fully

Limb and neck weakness

• Difficulty holding the head up, especially late in the day
• Weakness in the arms when reaching above shoulder height (e.g., combing hair, hanging clothes)
• Weakness in the legs, with difficulty climbing stairs or standing up from a low chair
• Tripping or unsteadiness when walking long distances

Breathing symptoms

When MG affects the muscles of breathing, it becomes a medical emergency called a myasthenic crisis. Warning signs include shortness of breath at rest, difficulty taking a deep breath, inability to clear secretions, choking on saliva, a weak cough, and a sense that talking in full sentences has become hard. These symptoms need urgent hospital assessment.

Symptoms typically fluctuate during the day and over weeks or months. Many people notice that symptoms are mildest in the morning after sleep and worsen as the day goes on, or after physical activity, illness, or heat exposure.

Diagnosis

Diagnosing myasthenia gravis usually involves a combination of clinical examination, blood tests, electrical nerve studies, and imaging. No single test gives the answer in every case, which is why neurologists often need to put several pieces together.

Clinical examination

A neurologist will ask about your symptom pattern — particularly whether weakness worsens with use and improves with rest. They will examine your eyes, face, voice, swallowing, and limb strength, often asking you to perform repeated movements (such as holding your gaze upward or counting aloud) to provoke fatigable weakness.

Blood tests for antibodies

Blood is tested for the antibodies described earlier — AChR antibodies first, and if negative, MuSK antibodies. Some centres also test for LRP4 antibodies. A positive result strongly supports the diagnosis. A negative result does not rule out MG, especially in ocular-only disease.

Nerve conduction and electromyography studies

Two specialised electrical tests are commonly used:

• Repetitive nerve stimulation (RNS): a nerve is stimulated several times in a row and the muscle response is recorded. In MG, the response gets smaller with each stimulation (called a decremental response).
• Single-fibre electromyography (SFEMG): a more sensitive test that records the timing of individual muscle fibres. It is the most sensitive test for MG but is uncomfortable and not available everywhere.

Bedside tests

The ice pack test is sometimes used for eyelid drooping — cold improves transmission at the neuromuscular junction temporarily, so a drooping eyelid that lifts after an ice pack is applied for a couple of minutes supports the diagnosis. The older edrophonium (Tensilon) test is now rarely used because the medication can cause heart-rhythm side effects and safer alternatives exist.

Imaging of the chest

Once MG is diagnosed, a CT scan or MRI of the chest is done to look at the thymus gland. This is important because a thymoma (a tumour of the thymus) is present in about 10 to 15 percent of people with MG and changes the treatment plan.

Tests for related conditions

Because MG can come with other autoimmune conditions, blood tests for thyroid function and sometimes for vitamin levels, diabetes, and other autoimmune markers are commonly done at diagnosis.

Treatment and Management

The aim of treatment in myasthenia gravis is to control symptoms, prevent flares, reduce the burden of medication side effects, and, where possible, induce remission. International consensus guidance describes a stepwise approach: symptomatic medication for everyone, immune-modifying treatment for most, thymus surgery for selected patients, and rescue therapies for severe disease or crisis.

Symptomatic medication: cholinesterase inhibitors

Pyridostigmine is the most commonly used medication for symptom relief. It works by blocking the enzyme that breaks down acetylcholine, so more of the chemical messenger remains available at the neuromuscular junction. It does not change the underlying immune problem but can significantly reduce day-to-day weakness. Side effects include abdominal cramps, increased salivation, sweating, and occasionally muscle twitching. The dose is adjusted to balance benefit against these effects. In MuSK-antibody MG, pyridostigmine is often less helpful and may even worsen symptoms; this is one reason knowing the antibody type matters.

Immunosuppressive treatment

Because MG is autoimmune, most people with generalised disease need treatment that calms the immune system. Several options exist and are often combined or sequenced.

Corticosteroids (prednisolone) are the most widely used immune-suppressing medication. They work relatively quickly, often within weeks. The dose is typically increased gradually to reduce the risk of an early worsening of weakness, and then tapered slowly once symptoms are controlled. Long-term side effects — weight gain, raised blood sugar, bone thinning, mood changes, increased infection risk — mean that doctors aim to use the lowest effective dose.

Steroid-sparing immunosuppressants are added so that the steroid dose can be reduced. Commonly used options include azathioprine, mycophenolate mofetil, methotrexate, ciclosporin, and tacrolimus. These medicines take several months to reach their full effect. They require blood tests to monitor for liver, kidney, and bone marrow effects.

Newer targeted therapies have emerged in recent years. Rituximab, an antibody-depleting medication, is used particularly in MuSK-MG and in refractory cases. Complement inhibitors such as eculizumab and ravulizumab block a part of the immune cascade that damages the neuromuscular junction; they are used in severe AChR-positive disease that has not responded well to standard therapy. FcRn inhibitors such as efgartigimod reduce circulating antibodies. The availability of these newer medications varies by centre.

Rescue therapies

• Plasma exchange (plasmapheresis): the patient’s blood is processed through a machine that removes the antibody-containing plasma and replaces it with a substitute. Benefits are seen within days and last for several weeks.
• Intravenous immunoglobulin (IVIG): a concentrated solution of antibodies from healthy donors is given through a drip over several days. The mechanism is complex but the effect is to dampen the abnormal immune response. Benefits are seen within one to two weeks.

Both are typically given in hospital and are not used for routine long-term control.

Thymectomy

Removing the thymus gland (thymectomy) has been shown in clinical trials to reduce symptoms and the need for steroids in selected patients with AChR-positive generalised MG, particularly those under 60 at diagnosis. It is also performed when a thymoma is found, regardless of age. The benefit develops over months to a couple of years.

Thymectomy can be done through the breastbone (transsternal approach) or through smaller incisions using video-assisted or robotic techniques (minimally invasive thymectomy). The choice depends on whether a thymoma is present, the size of the gland, and surgical expertise. In MuSK-positive MG, the role of thymectomy is less clear and it is not routinely recommended.

Myasthenic Crisis

Common triggers include chest infections, surgery, certain medications, missed doses, and sometimes no identifiable cause.

Warning signs include:

• Increasing shortness of breath, particularly when lying flat
• Difficulty completing sentences without pausing for breath
• A weak cough or inability to clear throat secretions
• Choking on saliva or food
• Increasing weakness of the neck, face, or limbs over hours to days
• Restlessness, sweating, or a racing heart from the effort of breathing

If these signs appear, the person needs emergency hospital care without delay. In hospital, treatment usually involves breathing support (sometimes mechanical ventilation), plasma exchange or IVIG, treatment of any infection, and adjustment of medications. With timely treatment, most people recover from a crisis, although recovery may take weeks.

Cholinergic crisis

Rarely, too much pyridostigmine can cause its own form of severe weakness, called a cholinergic crisis, with overflow effects such as heavy salivation, abdominal cramps, diarrhoea, sweating, and small pupils. This can look similar to a myasthenic crisis but requires the opposite response — reducing rather than increasing the cholinesterase inhibitor. It is one of the reasons crises are managed in hospital with neurological input.

Lifestyle and Self-Management

Living well with myasthenia gravis involves more than taking medication. Day-to-day habits and self-awareness make a meaningful difference for many people.

Pacing and energy management

Because weakness worsens with use, planning activity in shorter bursts with rest in between is often more effective than pushing through. Many people find it helpful to:

• Schedule demanding tasks earlier in the day, when strength is usually best
• Break long tasks into smaller segments with short rests
• Sit rather than stand for tasks where possible (cooking, ironing, brushing teeth)
• Use lightweight tools and equipment that reduce effort

Heat and environment

Many people with MG find that heat worsens their weakness. Air-conditioned environments, cool showers, and avoiding the hottest part of the day during summer can help. Cool compresses on the eyelids may briefly help with droop.

Nutrition and swallowing

If chewing or swallowing tires you, softer foods, smaller bites, and pausing during meals can help. Eating the largest meal of the day when energy is highest, rather than in the evening, is often more comfortable. If choking or coughing on food becomes common, a speech and language therapist can carry out a swallowing assessment and suggest safer textures and techniques.

Sleep

Good sleep matters more in MG than for most conditions, because muscles recover during rest. Sleeping with the head slightly elevated can help with breathing comfort in those with weaker respiratory muscles.

Exercise

Gentle, regular exercise is generally encouraged, tailored to the individual’s strength. The aim is not to push muscles to exhaustion but to maintain conditioning. Aquatic exercise is often well tolerated. A physiotherapist familiar with neuromuscular conditions can help design a programme.

Vaccinations and infections

Infections, particularly chest infections, are a common trigger for flares. Staying up to date with seasonal vaccinations is recommended. Live vaccines may need to be avoided or timed carefully in people on immune-suppressing medication; your neurologist will advise on what is appropriate for you.

Avoiding problem medications

Several medications can worsen MG. It is helpful to:

• Carry a card or wear identification noting that you have MG
• Tell every doctor, dentist, pharmacist, and anaesthetist you see about your diagnosis
• Check with your neurologist before starting any new medication, including over-the-counter drugs

Monitoring and Follow-up

MG is a long-term condition and is followed up by a neurologist, usually every few months when starting or adjusting treatment, and less often once stable. Visits typically include:

• A symptom review and structured assessment of weakness (sometimes using scales such as the MG-ADL or QMG score)
• Review of medication doses and side effects
• Blood tests when on immunosuppressants (for liver, kidney, blood counts)
• Bone density monitoring for those on long-term steroids
• Eye, blood pressure, and blood sugar checks as relevant
• Discussion of triggers, recent infections, and any flares

The aim, described in international consensus guidance, is to reach a state of minimal manifestations — meaning no functionally limiting symptoms and only minor weakness on examination — with the least possible burden of medication side effects.

Living with Myasthenia Gravis

Work and daily life

Most people with well-controlled MG continue to work, study, and care for their families. Some need workplace adjustments such as flexible hours, the option to sit, breaks during long meetings, or reduced exposure to heat. Physically demanding jobs may need modification. An open conversation with an employer, supported by a letter from your neurologist if needed, often helps.

Driving

Double vision or significant eyelid droop can affect safe driving. If your eye symptoms are active or changing, your doctor will advise whether and when driving is appropriate.

Pregnancy and family planning

MG does not usually prevent pregnancy, and most pregnancies in women with MG go well, although symptoms can fluctuate during and after pregnancy. Planning ahead with both a neurologist and an obstetrician is important, because some MG medications are not suitable in pregnancy and need to be changed before conception. The newborn may have temporary MG-like symptoms (transient neonatal myasthenia) for a few weeks because of antibodies crossing the placenta; this is managed by the paediatric team and resolves on its own.

Surgery and anaesthesia

If you need surgery for any reason, the surgical and anaesthesia team should know in advance that you have MG. Some muscle relaxants used during general anaesthesia behave differently in MG, and the anaesthetist will choose drugs and doses accordingly. Plasma exchange or IVIG is sometimes given before major surgery to optimise strength.

Mental health

Living with a fluctuating condition that affects appearance (eyelid droop, facial weakness), speech, and daily energy can take a real toll. Anxiety and depression are more common in people with MG than in the general population. Support groups, counselling, and being open with family about what you experience are all part of long-term care.

Complications and Long-term Outlook

The outlook for myasthenia gravis has improved substantially over recent decades. With current treatment, most people achieve good day-to-day control and a normal life expectancy. The condition that was once called “grave” for good reason is now, for most patients, a manageable long-term illness.

Possible complications and concerns include:

• Myasthenic crisis — as described above, severe respiratory weakness requiring hospital care
• Aspiration pneumonia — if swallowing is weak, food or liquid can enter the airway
• Side effects of long-term immunosuppression — including infection risk, bone thinning, weight gain, raised blood sugar, and (with some medications) a small increase in long-term cancer risk
• Thymoma — if present, this needs its own oncological follow-up after surgery
• Coexisting autoimmune conditions — thyroid disease in particular is common and should be checked for periodically

Some people experience remission, in which symptoms disappear, sometimes off medication. Remission is more common after thymectomy and in younger patients but is not predictable in any individual case.

Myasthenia Gravis in Children

Although MG is mostly a condition of adults, it can occur in children, and the considerations differ in important ways.

Juvenile myasthenia gravis

Juvenile MG is the term used when autoimmune MG begins before age 18. It can present at any point in childhood. In younger children, eye symptoms (drooping eyelid, double vision) are often the first sign. In adolescents, the pattern can resemble adult-onset disease.

The diagnostic approach is similar to adults — antibody testing, nerve conduction studies, and chest imaging — with extra attention to ruling out the congenital myasthenic syndromes described below. Treatment uses the same general principles, but doses, choice of immunosuppressant, and decisions about thymectomy are individualised to growth, schooling, and developmental considerations. Many children with juvenile MG do very well, and remission rates appear to be higher than in adults.

Transient neonatal myasthenia

Babies born to mothers with MG can have temporary weakness, poor feeding, weak cry, or breathing difficulty in the first days of life because of antibodies that crossed the placenta during pregnancy. Symptoms usually resolve within a few weeks. Affected babies are observed in hospital and treated supportively until the antibodies clear.

Congenital myasthenic syndromes

These are rare inherited conditions in which the neuromuscular junction itself has a genetic problem — not an autoimmune one. They can look like MG, especially in infancy or early childhood, but they do not respond to immune-suppressing treatment. Diagnosis is by genetic testing. Treatment depends on which gene is involved; some forms respond to specific medications, and care is led by a paediatric neurologist with experience in neuromuscular disease.

School and daily life

For children with MG, schools can usually accommodate the condition with awareness and small adjustments: rest breaks, permission to sit during assembly, modified physical education, and a plan for what to do if symptoms worsen at school. Most children take part in age-appropriate activities, with adjustments during flares.

Preventing Flares and Progression

While MG cannot be cured in most cases, much can be done to reduce the frequency and severity of flares. Practical steps include:

• Taking medication consistently and at the prescribed times
• Not stopping or changing doses without speaking to your neurologist
• Treating infections promptly — including dental infections and urinary tract infections
• Keeping a written list of MG-aggravating medications to share with any new clinician
• Getting recommended vaccinations
• Pacing activity, especially during periods of stress or illness
• Keeping appointments for blood tests and follow-up

Keeping a simple symptom diary, especially when starting or changing treatment, helps you and your neurologist see patterns that may not be obvious from memory alone.

When to Seek Urgent Care

Most MG symptoms can be managed in scheduled clinic visits. Some, however, need urgent or emergency attention. Seek immediate medical help if you experience:

• Shortness of breath at rest or when lying flat
• Difficulty swallowing your own saliva or repeated choking
• A weak cough that cannot clear secretions
• Sudden, severe worsening of weakness over hours or a day
• High fever with worsening MG symptoms
• Symptoms of a chest infection alongside increasing weakness

These can be signs of myasthenic crisis or a serious infection on the background of MG. It is better to be assessed and reassured than to wait at home.

Frequently Asked Questions

Is myasthenia gravis curable?

MG is not usually cured in the sense that the underlying tendency goes away forever, but it is highly treatable. Many people reach a state where symptoms are minimal or absent on treatment, and some achieve lasting remission, particularly after thymectomy.

Is MG genetic? Will my children get it?

Most cases of autoimmune MG are not inherited. The chance of a child of someone with MG developing the same condition is small. A family history of autoimmune conditions in general is more common. Congenital myasthenic syndromes, by contrast, are genetic and are different from autoimmune MG.

Can MG affect the heart?

MG affects voluntary skeletal muscle, not heart muscle. However, in people with thymoma, there can be associated heart muscle inflammation in rare cases, and certain MG medications and treatments can affect heart rhythm or blood pressure. Routine heart checks are reasonable, particularly for those with thymoma or on certain medications.

Will I be on medication for life?

Many people remain on some form of treatment long term, although doses are often reduced over time as the condition stabilises. Some people are able to come off medication entirely, especially after successful thymectomy. The plan is reviewed at each visit.

Is exercise safe?

Gentle to moderate, well-paced exercise is generally encouraged. The principle is to maintain conditioning without pushing muscles to exhaustion. A physiotherapist can help tailor a programme.

Can I drink alcohol?

Moderate alcohol is not specifically forbidden, but alcohol can interact with some medications and worsen tiredness. Discuss with your neurologist, particularly if you are on immunosuppressants that affect the liver.

Why do my symptoms feel different on different days?

Day-to-day fluctuation is a defining feature of MG. Sleep, infection, heat, stress, hormonal cycles, recent activity, and time since the last medication dose all influence how strong you feel. Tracking patterns can help identify your personal triggers.

Does pregnancy worsen MG?

Pregnancy affects MG unpredictably — symptoms may improve, worsen, or stay the same. The first trimester and the weeks after delivery are times of higher flare risk. Planning the pregnancy with both a neurologist and an obstetrician, and reviewing medications beforehand, helps keep both mother and baby safe.

Is it safe to have surgery if I have MG?

Surgery is regularly performed in people with MG, including major operations. The key is that the surgical and anaesthesia team know about the diagnosis well in advance, so they can plan medication timing, choose appropriate anaesthetic drugs, and arrange post-operative monitoring.

Can MG go away on its own?

Spontaneous remission can occur but is not the rule. Most people benefit from active treatment, and waiting for the condition to resolve on its own is not the typical approach.

Conclusion

Myasthenia gravis is a chronic autoimmune condition that affects how nerves communicate with muscles, producing weakness that fluctuates with use and rest. It can range from a purely ocular problem to a generalised illness that affects breathing, and it can begin in childhood, young adulthood, or later life.

Treatment today is more effective and better tolerated than ever before. The combination of symptomatic medication, immune-modulating therapy, selective surgery, rescue treatments for flares, and attentive long-term monitoring means that most people with MG can expect a good quality of life. Newer targeted therapies are continuing to expand what is possible, particularly for people whose condition has been hard to control.

Living well with MG means working closely with your neurologist, knowing your own pattern of symptoms and triggers, taking medication consistently, recognising when to seek urgent care, and giving yourself room to pace activity and rest. With this combination, MG becomes a condition you manage — not one that defines your days.